Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that post-COVID syndrome symptoms persisted and were more common in individuals who had recovered from COVID-19 compared to uninfected controls in Kerala, though both groups showed significant symptom burdens.

This study suggests that integrating barber care with medical treatment improves scalp condition and psychological well-being in early stages of hair loss, by enhancing medication efficacy and reducing stress.

The abstract discusses the multidisciplinary nature and advancement of dermatology and aesthetic procedures within the health sciences, emphasizing the integration of diagnostic, corrective, preventive, and therapeutic approaches, but does not provide specific study results.

This study found that among office workers in Seoul and Gyeonggi Province, hair loss stress significantly correlates with increased interest in appearance and consumption of scalp care products, with variations in impact depending on the type of stress experienced.

This study analyzed Yul Brynner's star image in 1950s Hollywood, highlighting how his distinct physical presence and flexible ethnic portrayals influenced his cinematic appeal, while examining the interplay of his unique performance style with biographical tales.

This study described the clinical characteristics of 18 pediatric patients with alopecia areata at a hospital in Denpasar from 2021 to 2023, finding equal gender distribution and hair loss as the most common symptom, with onset typically within 1–6 months.

This study found that negative societal perceptions of individuals with baldness, such as being seen as less confident, attractive, or older, are predominantly influenced by social stereotypes and a lack of understanding about the medical causes of baldness.

This study observed that patients with AA showed a high willingness to trade off lifespan for better disease-specific quality of life, indicating a significant disease burden.

In this study, researchers observed significant racial disparities in alopecia quality of life research, with fewer studies and less funding focusing on Black patients compared to other racial groups, indicating a need for more inclusive and diverse participant recruitment.

Alopecia areata significantly harms women's self-image, causing reduced confidence and social isolation.

In this study, Erianin was found to significantly suppress alopecia areata in a mouse model by inhibiting effector T cell function, reversing systemic symptoms, and promoting hair growth.

This study developed an ointment from palm kernel oil and shea butter, which demonstrated improved hair growth in rabbits and may inform the creation of non-harmful hair growth products for humans.

This study found that pulse corticosteroids effectively induce hair regrowth in alopecia areata, with betamethasone showing higher efficacy but more side effects, and treatment success varying depending on age, onset time, and disease type.

In this study, the researchers found that awareness of appearance due to hair loss positively impacted hair loss management behaviors through self-awareness and psychological factors, but appearance management intention did not influence care behaviors.

This study concluded that thiocyanate promotes new cell formation and hair growth in animals and humans, with therapeutic effects seen in 51% of human alopecia areata cases after treatment, attributed to diverse biological mechanisms.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

In this study, 27.9% of Parkinson's disease patients reported hair loss, with a higher incidence linked to a daily levodopa-equivalent dose over 448 mg, suggesting an association between dopaminergic medication use and hair loss complaints.

In this study, the researchers identified traumatic styling practices, such as frequent hair straightening, as a dominant cause of alopecia among women aged 15 to 45 in a dermatology setting, noting that rural women also experienced inflammatory alopecia linked to different etiologies.

In a clinical observation study, researchers documented a case of total alopecia in an 11-year-old child, highlighting a potential link to genetic conditions such as autoimmune polyendocrinopathy candidiasis-ectodermal dystrophy (APECED syndrome) requiring further genetic and serological testing to verify the diagnosis.

This study found that clinical characteristics, concurrent medical conditions, and hair care practices may affect treatment outcomes in patients with central centrifugal cicatricial alopecia.

This case report describes significant improvements in both trichotillomania and bulimia symptoms with N-acetylcysteine treatment, suggesting a potential shared pathophysiological mechanism between the disorders.

In this study, all patients receiving chemotherapy for breast carcinoma experienced chemotoxicities like hair loss, nausea, and fatigue, with no one regimen identified as more toxic than another.

This study found that hair transplant surgery significantly reduced anxiety scores in bald patients over an average period of 12.7 months.

This study explored the experiences of adolescents with alopecia and their parents, highlighting the emotional distress caused by the condition and the inadequate response of healthcare professionals to their needs.

This review discusses the evaluation methods for patients with hair loss, emphasizing the importance of history, physical examination, and, when necessary, laboratory tests or biopsy, but it reports no new clinical results.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

In this review, the authors examine the causes, risk factors, and management strategies for chemotherapy-induced hair loss, highlighting its psychological impact and underscoring the role of healthcare providers, especially nurses, in supporting patients through this distressing side effect.

This review discusses telogen effluvium, a common form of hair loss, and reports no new clinical results; the authors outline possible causes, typical prognosis, and management strategies.

This study reviews drug-induced hair changes, noting that hair loss often reverses after stopping the drug, but permanent alopecia cases post-chemotherapy are rising.

This review discusses various treatment options for alopecia areata, focusing on manipulating the immune response around hair follicles, but reports no new clinical results.